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That viruses can induce cancer in experimental animals requires no further 
proof. However, it is increasingly apparent that, even in the case of neoplasms 
known to be virus induced, the initial infection of a cell with a  "tumorigenic" 
virus is only one event among a set of events and conditions which c~llmlnates 
in malignant tumors. Until the nature of these various factors can be eluci- 
dated,  our  understanding  of  viral  tumorigenesis  and  the  development  of 
malignancy will remain incomplete. 
The analysis of genetic differences between animal hosts of the same species 
which are, respectively, susceptible to and refractory to the tumorigenic effect 
of a  given virus is an approach which may ultimately aid in defining the es- 
sential steps leading to malignancy. Thus, working with the Gross leukemia 
virus (1),  which induces predominantly lymphoid neoplasms of thymic origin 
in susceptible mouse strains, we have previously shown (2, 3)  that a  major 
determinant of susceptibility to  Gross virus  leukemogenesis is  a  gene  lying 
within or closely linked to Histocompatibility-2  (H-2), a highly complex locus 
governing the strongest set of histocompatibility and blood group antigens of 
the mouse. However, little is known concerning the critical events which occur 
or fail to occur in Gross virus-susceptible mice during the prolonged period of 
latency preceding the appearance of leukemia. Therefore, it has not yet been 
possible to determine the basic mechanism of the H-2-associated susceptibility 
gene. 
The Friend leukemia virus (4), in comparison with the Gross virus, induces 
an entirely different disease syndrome in susceptible mice, with a pronounced 
splenomegaly resulting  from  an  almost  explosive  outgrowth  of  reticuloen- 
dothelial elements as the most obvious early symptom, followed eventually by 
the appearance of cells of a more frankly malignant histological appearance (5). 
Earlier experiments in our laboratories indicated an association between lt-2 
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type and susceptibility to the Friend disease syndrome (6).  The experiments 
reported here confirm this finding with respect to the F-B strain (7) of Friend 
virus. The influence of H-2  type is  reflected  in (a)  the  threshold virus dose 
required for the induction of  the  Friend disease, and (b)  the incidence of re- 
covery  from  the  early  splenomegalic phase  of  the  disease  syndrome.  These 
H-2-associated effects are dependent upon the presence of a  susceptible pheno- 
type  with  respect  to  the  Friend virus  susceptibility gene  demonstrated  by 
Odaka  (8)  and by Axelrad (9),  but this latter gene segregates  independently 
with respect to the 11-2 locus. 
Materials and Methods 
M~.e.--AU the mice in these experiments were from our own colony of highly inbred mouse 
strains. The parental inbred strains, with their H-2 genotypes, were: DBA/2 and BALB/- 
c-T(H-2d), and C57BL/6  (H-2b). The BALB/c-T strain also carries the dominant muta- 
tion, brachy (7"),  which is linked to//-2. In addition, certain F1 hybrids, as well as segregating 
backcross and F2 generation mice, were studied. The mice were usually 6-10wk old at the time 
of virus inoculation, and thereafter the degree of their splenomegaly, if any, was determined 
by palpation at frequent intervals for 2 or more months. 
H-2 Typing.--Ascertainment of the H-2 phenotypes of mice of segregating generations was 
performed on erythrocytes obtained by retro-orbital bleeding. The method was a modification 
of the hemagglutination technique of Corer and Mikulska  (10), using isoimmune sera ob- 
tained following three or more inoculations of normal lymphoid tissues or tumor cells into the 
appropriate allogeneic serum donors. 
Friend Virus.--The variant F-B strain of Friend virus (7) was used exclusively  in these ex- 
periments. It differs from the parental F-S virus strain most strikingly in its relative infec- 
tivity in mice of the DBA and BALB strains. Whereas the F-B virus strain is about equally 
infective in DBA and in BALB mice, the F-S parental virus strain is about one hundred times 
more infective in DBA mice than in BALB mice, according to the spleen focus assay (11). 
Susceptibility to F-B virus is dominant in crosses involving BALB or DBA mice (susceptible) 
and C57BL mice (resistant). 
Virus preparations were obtained from the greatly enlarged spleens of BALB or DBA mice 
infected 2-3 wk previously with F-B virus from an isogeneic  donor. The spleens were homog- 
enized in nine times their weight of cold phosphate-buffered saline. Slow centrifugation at 4°C 
removed the large particulate matter from the homogenate, and the superuatant was recentri- 
fuged for 4 min at 7000 g. This second supematant, either as such or after filtration through 
Selas 02 filter candles, was the basic 1:1 dilution virus inoculum. When assayed in DBA or 
BALB mice, such preparations contain 3.5 4- 2.0 (SD) X  104 focus-forming  units (11) per 0.2 
ml. 
RESULTS 
1t-2 and the Threshold  Virus Dose for the Induction of Friend Disease.-- 
Intraperitoneal inoculation of 0.2  ml of full-strength vires preparations into sus- 
ceptible DBA mice or (C57BL  ×  DBA)  F1 hybrids results in a  100% incidence of 
splenomegaly which is first detectable by palpation at about 7-10 days and which 
attains its maximal degree at 14-18 days. Recovery from the disease is virtually non- 
existent in these mice at this dosage level. C57BL mice, on the other hand, show no 
significant splenomegaly following this treatment. FRANK  LILLY  467 
Following inoculation of similar full-strength F-B virus preparations in a population 
of (C57BL  X DBA)  ×  C57BL backcross mice, significant splenomegaly appeared in 
38 of 81 mice (47%), a proportion consistent  with the interpretation that a  single 
genetic locus determines susceptibility  or resistance to the virus under these conditions. 
This result agrees, in general, with the finding of Odaka (8) and Axelrad (9) concerning 
single gene determination of susceptibility  to their respective strains of Friend virus, 
using other mouse strain combinations and different methods of scoring susceptibility 
and resistance in individual mice. 
At this high dosage level of the virus, no correlation was seen between virus 
susceptibility (splenomegaly) and H-2 type: 17 of 41 heterozygous tI-2b/tt-2  a 
segregants (42 %; P  --- 0.19) showed splenomegaly, and 21 of 40//-2  b homozy- 
gores (52 %) showed splenomegaly. From these data, it may be concluded that 
H-2 and the gene determining this splenomegalic response to F-B virus segre- 
gate independently. 
Another group of mice of this same (C57BL  X DBA) ×  C57BL backcross genera- 
tion was inoculated with 0.2 ml of a 1:10 dilution of the F-B virus preparation. In the 
population as a whole, 77 of 170 mice (45%)  developed splenomegaly, a proportion 
not significantly different (P -- 0.21) from the expected 50%. However, when the cor- 
relation between H-Z type and development of splenomegaly was examined, a signifi- 
cant difference appeared: 42 of 77 H-Zb/H-2 d heterozygotes (54%) were snsceptible, 
while only 35 of 93 H-2  b homozygotes  (38%)  were susceptible,  this latter fraction 
being significantly different (P -  0.02) from the expected 50%. 
A further group of (C57BL  X DBA) X C57BL backcross mice were similarly inoc- 
ulated with a 1 : 100 dilution of the basic virus inoculum. At this dosage levd, only 12 
of 69 mice (17%; P  <  0.001) showed splenomegaly, and all of these were among the 
36 tt-2b/H-g d segregants in the population; no lt-2  s homozygotes showed significant 
splenomegaly. 
The  results  of  these  three  experiments  are  illustrated  in  Fig.  1.  Among 
heterozygous tt-2b/~t-2 d  segregants,  the  incidence  of splenomegaly did  not 
differ significantly from the expected 50 %  at a  1:1 or a  1:10 dilution of the 
virus preparation, and this incidence decreased with only minimal statistical 
significance (P  =  0.04)  even at a  1:100 dilution of the virus inocnlum. By 
contrast,  the  expected 50%  incidence  of  splenomegaly among  homozygous 
1t-2  b mice was seen only with full-strength virus preparations; at a  1:10 virus 
dilution, significantly fewer than 50 %  of the mice were susceptible, and at a 
1:100 dilution, the incidence of splenomegaly decreased to zero. 
tt-2 and Recovery from Friend  Virus-Induced  Splenomegaly. u 
In the previous section, an animal was considered susceptible to F-B virus 
if it had  shown  significant splenomegaly at palpation  (representing an  esti- 
mated minimum increase to four times its normal spleen weight) at any time 
during the 2 or more months of observation. In this section, our consideration 
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Among the 38 backcross mice which developed splenomegaly following inoculation 
d  full-strength  F-B  vLrus preparations,  eight  mice  (21%)  recovered  from  their 
splenomegaly and regained a normal spleen size either transiently or permanently for 
the length d  the observation period. All eight of these mice were among the 21 homo- 
zygous H-2  b susceptible segregants.  This recovery phenomenon was never seen among 
DBA or (C57BL  ×  DBA) F~ mice at this level d  virus dose. 
At the dosage level of a  1:10 dilution of the virus inoculum,  33 d  77 mice (43%) 
recovered from their splenomegaly. Again,  a  strong corrdation with H-2 type was 
apparent: 26 of 35 H-2  b homozygotes (74%)  recovered, while only 7 of 42 H-gb/H-g ~ 
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FIo. 1. The incidence of splenomegaly  in mice of the (C57BL/6 X DBA/2)  X C57BL/6 
backeross generation, according to H-2 type, following inoculation of a 1:1, 1:10, or 1:100 
dilution of standard F-B virus preparations. 
heterozygotes (17%) did so. When the virus inoculum was reduced to a  I:100 dilu- 
tion--a  dilution  at  which  none  of  33  /t-g  b  homozygotes  showed  detectable 
splenomegaly--7 of the 12 susceptible H-gb/H-g d heterozygotes (58%) recovered at 
least transiently. 
These data are compiled in Fig.  2,  showing  the pronounced differences  at each 
dosage level in the recovery rate from F-B vires-induced splenomegaly among the two 
classes with respect to H-? type. 
This correlation  between 1t-2  type and recovery from Friend  disease was 
also seen in another series of experiments, in which segregating generations of 
the  cross  BALB/c-T  (susceptible)  X  C57BL  (resistant)  were observed fol- 
lowing challenge with full-strength preparations of F-B  virus. An  additional 
genetic  marker was present  and  segregating  in  these  crosses:  the  dominant 
gene brachy (T), which causes abnormalities in the tails ("short-tail") of hetero- 
zygotes (T/q-), with a penetrance of about 85-95 % in the crosses studied here. 
Brachy is lethal at an early embryonic stage for homozygotes (T/T). The brachy FRANK  LILLY  469 
locus is in the ninth  llnkage group of the mouse, being linked to H-Z with a 
recombination frequency of about 15 % in females and 5 % in males. 
BALB males heterozygous for brc~hy (H-2dT/H-2d+)  were mated with normal 
C57BL females. Short-tail F1 females (H-2dT/H-2b+) were then crossed with C57BL 
"males to provide the backcross generation, and short-tail FI males were mated with 
normal-tail F1  females to produce  the  F2  generation  (H-2dq-IH-Zbq  -  X  H-2dTI 
H-2b+). 222 backcross and 252 F2 generation mice were observed for their response to 
inoculation of full-strength F-B virus, and the results are summarized in Table I. 
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Fzc. 2. The incidence of recovery from splenomegaly  induced by inoculation of a 1:1, 1:10, 
or 1:100 dilution of standard F-B virus preparations in susceptible mice of the (C57BL/6 X 
DBA/2)  ×  C57BL/6 backcross generation, according to H-2 type. No mice of the homo- 
~¢gous H-Z  b type developed splenomegaly foUowing inoculation of a 1:100 dilution of the 
virus preparation, and the broken line in the chart indicates that the incidence of recovery 
among these animals might be expected to approach 100% at about the same virus diintion 
at which the incidence of splenomegaly  among them (Fig. 1) approaches zero. 
Analysis of these  data  reveals that  the  incidences  of splenomegaly corre- 
sponded closely to those expected on the assumption that a single genetic locus, 
independent  of H-2,  determines susceptibility and resistance to F-B  virus in 
these mice. 
With respect to recovery from splenomegaly in susceptible segregants from 
these crosses, this phenomenon was again,  as in the  C57BL  X  DBA crosses 
described above, strongly associated with the homozygous H-2  b type. In addi- 
tion,  the  association  of  this  recovery phenomenon  with  the  absence  of  the 
brachy trait was ~lmost as pronounced as its association with the homozygous 
H-2  b type. Thus, the genetic factor responsible for this ability to recover from 
splenomegaly was again clearly situated within the region of the ninth linkage 
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and the quantitative nature of the effects of the gene governing recovery from 
splenomegaly make it impossible to obtain from these data a  definite linear 
ordering of the genes. 
Three coat color traits were also segregating in these BALB X  C57BL crosses, 
controlled by the genes agouti (linkage group V), brown (VIII), and albino (I). 
There was no association between the occurrence of any of these traits and 
either susceptibility to splenomegaly or recovery from splenomegaly. 
TABLE I 
Inddowe of Splenomegaly and of Recovery  from Splenomegaly among Mice of the (C57BL  X 
BALB/c-T)  X  C57BL Backcross and the (C57BL  X  BALB/c-T) F2 Generations, 
According to H-2 (A) and Br~hy (B) Pkenotypes 
Phenotype 
Backcross generation: 
A. H-gb/H-2 d 
H-gb/H-g b 
B. Short-tail 
Normal-tail 
F~ generation: 
A. H-gd/H-2 d 
H-2b/H-2 d 
H-~b/H-~ b 
B. Short-tail 
Normal-tail 
Incidence of splenomegaly 
No.  % 
56/112  50 
48/110  44 
46/93  49 
58/129  45 
44/56  79 
92/132  70 
43/64  67 
86/109  79 
93/143  65 
Incidence  of recovery among 
splenomegallc  mice 
No.  % 
4/56  7 
39/48  81 
5/46  ii 
38/58  66 
1/44  2 
2/92  2 
19/43  44 
3/86  3 
19/93  2O 
DISCUSSION 
These studies of response to the F-B strain of Friend virus indicate that, in 
the crosses studied, essential susceptibility to the induction of splenomegaly at 
high virus doses is determined by a  single gene, with a  dominant allele for 
susceptibility  and  a  recessive  allele  for  resistance,  which  segregates  inde- 
pendently with respect to 1t-2. However, this essential susceptibility is markedly 
influenced by the host's genotype with respect to H-2 or a  gene closely as- 
sociated with it. In mice with an essentially susceptible genotype, H-2  type 
influences the threshold virus dose required for the induction of splenomegaly 
and also the prognosis for recovery from splenomegaly at a given dosage level 
of virus. 
It is important to emphasize that the influence of H-2 in these experiments 
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genotype is required for its expression. Thus, with respect  to the (C57BL  × 
DBA)  X  C57BL backcross generation,  for example, a high dose of F-B virus 
can be selected at which the expected 50 % of mice of both H-2 types become 
splenomegalic, and a  low dose of virus can be selected at which no mice of 
either t/-2 type respond  with splenomegaly;  however,  intermediate doses of 
virus can be selected at which the incidence of splenomegaly is markedly re- 
duced  among  H-Z  b  homozygotes  but  not  among  heterozygous  H-2b/H-2  d 
segregants.  The H-2-associated gene apparently has no effect in the absence 
of an essentially susceptible genotype. 
It seems likely that the greater rate of recovery  from splenomegaly,  at a 
given virus dosage level, among the H-2  b homozygotes as compared with the 
H-2b/H-2  d  heterozygotes  in the population might be a  further reflection  of 
the same basic mechanism by which tt-2  influences the virus dose threshold 
for the  splenomegalic  response.  Whatever this underlying mechanism is,  it 
appears to take effect only after cellular infection and virus proliferation have 
begun,  so that it seems unlikely to depend upon the presence or absence of 
hypothetical virus receptor sites on the cell surfaces. 
A  more  likely hypothesis is  that  the 11-2-associated  gene  influences  the 
ability of the host to stage an effective immunological response to the virus 
or to virus-induced  antigens of infected cells (12). McDevitt (personal  com- 
munication) has found that the genes governing the level of antibody response 
in mice to two synthetic polypeptide antigens are closely associated  with the 
11-2 locus. Similarly, Aoki et al. (13) found natural antibody to the G (Gross) 
leukemia antigen in homozygous 11-2  b  and in heterozygous  11-2k/11-Z  °  segre- 
gants but not in homozygous  11-2  k  segregants from crosses of AKR (11-2 k, 
G-t-) and C57BL (H-2  b, G-). It remains problematic  whether such determi- 
nants of immunological  responsiveness  act by direct genetic  control of the 
antibody-combining sites  or by some other mechanism.  One may speculate, 
for example, that some isoantigen  determined by the 11-2 d allele but not by 
11-2  u  cross-reacts  to  some  extent  with  an  important  Friend virus-induced 
antigen; thus mice possessing an 11-2  d allele would, by reason of their immu- 
nological  tolerance  for the particular H-2  d component,  be impaired in their 
ability to respond to the virus-specific antigen, as well. 
On the other hand, nonimmunological mechanisms may also be postulated 
to explain  the effect of 11-2  on response  to F-B virus.  Perhaps the cellular 
milieu in homozygous 11-2  b mice does not permit replication  of the virus as 
rapidly or efficiently as that in mice  of other 11-2  types, so that the host's 
immunological response is more efficient in eliminating the infection. Alterna- 
tively, some difference in interferon production according to 1t-2 type could 
conceivably explain the association. 
Our unpublished  studies of susceptibility  to the F-S strain of Friend virus 
in the (C57BL X DBA)  X DBA backcross and the (BALB X C3H/Bi) F2 gen- 472  1t-2  TYPE  AND  FRIEND  LEUKEMIA  VIRUS 
eration have so far revealed no significant association between H-2 type and 
response to this virus strain.  However,  the homozygous H-Z  b  type does not 
occur in these crosses, and experiments in the (CS7BL X DBA) F2 generation, 
where  it does  occur,  are now  underway to determine the response  of H-2  u 
homozygotes to F-S virus. 
The observations  of Fefer et al.  (14) concerning the spontaneous regression 
rates of tumors induced in newborn  mice  with the Moloney sarcoma  virus, 
which is antigenically related to the Friend virus, may be of a similar nature 
to the findings reported here.  Newborn BALB/c, C57BL/6,  and (BALB  X 
C57BL) F1 mice were all equally susceptible to tumor induction by the virus, 
but the regression rates of the tumors in  the three groups  of mice differed 
greatly: 3% in BALB mice, 24% in the F] hybrids, and 47% in C57BL mice. 
Studies of the mechanism underlying the association  of H-2  type and re- 
sponse to Friend virus should be greatly facilitated by the use of mouse strains 
congenic with each  other but differing with respect  to the 1t-2 chromosomal 
segment. We are currently undertaking a breeding program designed to create 
a DBA/2-H-2  b and a  BALB/c-H-2  s  strain. The existing congenic pair, C3H/ 
DiSn (//-2  k) and C3H.SW  (H-2  b) may also prove useful in this regard. 
su'M-~y 
Two types of quantitative response  to the F-B  strain of Friend virus in 
segregating generations of a cross involving a susceptible (DBA/2 or BALB/c; 
H-2  d) and a resistant (C57BL/6; H-2  b) mouse strain show a marked correla- 
tion with the H-2 type of the mice. Essential susceptibility,  as determined by 
the splenomegalic response  to high virus doses, is controlled  by a single pair 
of alleles which segregates independently with respect to the H-2 locus. How- 
ever,  relative  susceptibility,  as  determined by the  incidence  of  the  spleno- 
megalic  response  at moderate or low levels of virus dosage,  is  significantly 
greater among mice homozygous or heterozygous for the H-2  a allele than among 
tt-2  b homozygotes in these populations.  In addition, the incidence of recovery 
from splenomegaly  induced by a  given  level of virus dosage is significantly 
greater in H-2  s homozygotes than in segregants of other tt-2 types among their 
littermates. Possible  mechnn;qms responsible for these effects are discussed. 
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